Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Outlook Therapeutics, Inc. (ONS)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Revenues  0.00.00.00.00.00.00.00.0
Cost of goods sold  0.00.00.00.00.00.00.00.0
Gross profit  0.00.00.00.00.00.00.00.0
            Gross margin          
Selling, general and administrative   [+]7.06.35.05.86.73.33.52.9
Research and development  11.10.59.011.212.29.99.98.5
Equity in earnings  0.00.00.00.00.00.0-0.40.4
Other operating expenses    0.9  -0.2  
EBITDA   [+]-18.1 -14.8-17.0-18.9-12.9-13.8-11.0
            EBITDA margin          
Depreciation and amortization  0.0 0.10.10.10.10.10.0
EBIT   [+]-18.1-6.9-14.9-17.0-18.9-13.0-13.8-11.0
            EBIT margin          
Non-recurring items   [+]  -0.9  0.2  
Interest expense, net   [+]0.40.20.4-0.4-0.40.40.30.3
Other income (expense), net   [+]-2.10.40.0-0.9-1.2-1.00.7-0.9
Pre-tax income  -20.7-6.7-14.3-17.5-19.7-14.5-13.4-12.2
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%  0.0% 0.0%0.0%0.0%
Net income  -20.7-6.7-14.3-17.5-19.7-14.5-13.4-12.2
            Net margin          
   
Basic EPS   [+]($0.08)($0.03)($0.07)($0.08)($0.09)($0.08)($0.09)($0.07)
Diluted EPS   [+]($0.08)($0.03)($0.07)($0.08)($0.09)($0.08)($0.09)($0.07)
   
Shares outstanding (basic)   [+]256.9256.7212.1220.5219.1188.2152.7168.4
Shares outstanding (diluted)   [+]256.9256.7212.1220.5219.1188.2152.7168.4
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy